Dr. Hiu Chun Lam completed his Ph.D. at the University of Adelaide under the supervision of A/Prof. Jonathan George, followed by postdoctoral training at Peking University under Professor Xiaoguang Lei. In 2020, Hiu joined the Molecular Imaging and Therapy Research Unit (MITRU) at the South Australian Health and Medical Research Institute (SAHMRI) as a radiochemist. In MITRU, Hiu develops the manufacturing process of radioisotopes and radiopharmaceuticals for clinical trials and special access schemes. He is also leading several pre-clinical projects including drug discovery program for novel radiopharmaceuticals.
Reported by 9News, Clinical Director of The Florey Professor Graeme Jackson was interviewed about the technology developed at the Australian Epilepsy project.
26 June 2025
Donanemab, developed by Lilly, is the first disease-modifying treatment for early-stage Alzheimer’s disease to be approved for use in Australia. The National Imaging Facility supported its developme
16 June 2025
A new national-scale molecular-imaging network that aims to improve cancer imaging, dementia diagnosis and treatment, and new radiopharmaceuticals was launched Saturday at the annual meeting for Austr
26 May 2025
For 10 years, SAHMRI’s Cyclotron and Radiochemistry Facility has been a quiet powerhouse in Australian medical research—advancing precision imaging and improving patient outcomes.
12 March 2025
Nicole Reyne, Ronan Smith, Patricia Cmielewski, Nina Eikelis, Mark Lawrence, Jennie Louise, Piraveen Pirakalathanan, David Parsons & Martin Donnelley
Read Publication
Parham Foroutan, Ryan D. Quarrington, Michael Pyrros Russo, Boyin Ding, Peter A. Cripton, John J. Costi, Claire F. Jones
Read Publication
Catherine G. Dimasi, Jack R.T. Darby, Stacey L. Holman, Megan Quinn, Ashley S. Meakin, Mike Seed, Michael D. Wiese, Janna L. Morrison
Read Publication
Esther Camp, Laura Gonzalez Garcia, Clara Pribadi, Sharon Paton, Krasimir Vasilev, Peter Anderson, Stan Gronthos
Read Publication